Table 1.

The results of SSTs in 2773 patients divided according to indication.

	Description of indication	Total (n)	% Pass (n)	% Fail (n)
1	Treatment with inhaled, intra-nasal or topical glucocorticoids	228	75.4 (172)	24.6 (56)
2	Treatment with oral or i.v. glucocorticoids	176	55.7 (98)	44.3 (78)
3	Post-operative assessment after pituitary surgery (without radiotherapy)	195	70.3 (137)	29.7 (58)
4	Post-operative assessment after pituitary surgery (with radiotherapy)	59	71.2 (42)	28.8 (17)
5	Pituitary adenoma (without surgery or radiotherapy)	264	89.8 (237)	10.2 (27)
6	Other conditions affecting the pituitary	175	77.1 (135)	22.9 (40)
7	Other tumours of the CNS	315	74.9 (236)	25.1 (79)
8	Adrenal disease (CAH, Addison's disease, adenoma, carcinoma)	74	39.2 (29)	60.8 (45)
9	Co-existent autoimmune disease (thyroid disease, type 1 diabetes mellitus, premature ovarian failure, vitiligo)	113	92.0 (104)	8.0 (9)
10	Hyponatraemia or hyperkalaemia	68	91.2 (62)	8.8 (6)
11	Hypoglycaemia	32	100 (32)	0 (0)
12	Hypotension, syncope, collapse	173	96.0 (166)	4.0 (7)
13	Fatigue, weight loss, malaise	178	92.7 (165)	7.3 (13)
14	Other indications, including critical care admission or not specified	723	91.6 (662)	8.4 (61)
		2773	82.1% (2277)	17.9% (496)